There are 101 resources available
30P - Molecular biomarkers by next generation sequencing predicting oncological outcomes in ovarian cancer patients
Presenter: Shira Peleg Hasson
Session: Poster Display session
31P - Survival outcomes in BRCA pathogenetic mutated, variant of unknown significance, and wild type ovarian cancer patients treated with PARP inhibitors
Presenter: Lucia Musacchio
Session: Poster Display session
32P - BRCA1/2 mutations in epithelial ovarian cancer: Treatment response and survival analysis in a Spanish tertiary University Hospital
Presenter: Isabel Miras Rodriguez
Session: Poster Display session
Resources:
Abstract
33P - The development of infrastructure for mainstream ovarian cancer genetic testing (DEMO)
Presenter: Ionut Funingana
Session: Poster Display session
Resources:
Abstract
34P - Immunocytochemical determination of EpCAM protein expression in ascitic fluid cells in the diagnosis of ovarian cancer using the SER1 test system
Presenter: Irina Kruglova
Session: Poster Display session
35P - Racial Disparities in Diagnosis, Histological Type,Treatment and Survival in Ovarian Cancer Patients in the US from 1992 to 2018: SEER-based Analysis.
Presenter: Eman Zin Eldin
Session: Poster Display session
36P - Factors associated with platinum resistance in ovarian cancer patients receiving neoadjuvant chemotherapy
Presenter: Qinglei Gao
Session: Poster Display session
37P - Obesity and ovarian cancer, a controversial risk factor
Presenter: Firas Baidoun
Session: Poster Display session
38P - Impact of 1-year COVID-19 pandemic in patients with ovarian carcinoma treated with chemotherapy based on a GLOBAL DATA NETWORK
Presenter: Luis Manso Sanchez
Session: Poster Display session
39P - Longitudinal Increases in Albumin-Adjusted Serum Calcium Predict Ovarian Cancer
Presenter: Gary Schwartz
Session: Poster Display session